Literature DB >> 3723493

A multicenter study of hospitalization in rheumatoid arthritis: effect of health care system, severity, and regional difference.

F Wolfe, S M Kleinheksel, P W Spitz, D P Lubeck, J F Fries, D Y Young, D M Mitchell, S H Roth.   

Abstract

During 1981, centers in Phoenix, Saskatoon, Stanford and Wichita monitored hospitalizations for 816 patients with rheumatoid arthritis. Admission rates varied 2-fold, and admissions for evaluation and treatment 10-fold across centers. Admissions were related primarily to disease severity, but in US centers, were reduced by a factor of 3 by prepaid health care. Length of stay was shortest in California (7.3 days), and longest in Saskatoon (16.3) where designated arthritis beds and government prepaid health care existed. Average charges for surgery were as high as $10,000 in Phoenix and as low as $4550 in Wichita. Charges and length of stay were unrelated to disease severity, but were responsive to health care delivery system, availability of facilities, and geographic and center variation.

Entities:  

Mesh:

Year:  1986        PMID: 3723493

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review.

Authors:  Hubertus Rosery; Rito Bergemann; Stefanie Maxion-Bergemann
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  The present and future of comprehensive outcome measures for rheumatic diseases.

Authors:  P W Spitz; J F Fries
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

Review 3.  A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings.

Authors:  D P Lubeck
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.

Authors:  M J Nuijten; P Engelfriet; K Duijn; G Bruijn; D Wierz; M Koopmanschap
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  Etanercept: a review of its use in rheumatoid arthritis.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

6.  The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis.

Authors:  A Zink; J Listing; M Niewerth; H Zeidler
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 7.  Epidemiology and burden of illness of rheumatoid arthritis.

Authors:  Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.